Sabra (SBRA) CFO Michael Lourenco Receives Award

What Happened Michael Lourenco, Executive Vice President, Chief Financial Officer & Treasurer of Sabra Health Care REIT, received an award of 4,158 stock units on August 31, 2026. The units were granted at $0.00 (dividend-equivalent stock units), so the reported acquisition value is $0. These are not open-market purchases or sales but additional stock units credited as dividend equivalents tied to previously granted performance units.

Key Details

• Transaction date: 2026-08-31 (reported on Form 4 filed 2026-09-02).
• Transaction type/code: Award/Grant (A); 4,158 stock units acquired @ $0.00 (value $0).
• Shares owned after transaction: Total beneficial ownership not specified in the provided excerpt. The filing notes 286,773 stock units (see footnote) that, upon settlement, will convert one-for-one into shares.
• Footnotes: F1 = these 4,158 units are dividend-equivalent payments credited on previously granted stock units under the Issuer’s 2009 Performance Incentive Plan and will vest/pay on the same terms as the original units. F2 = 286,773 stock units noted that will be settled one-for-one in common stock.
• Exhibit: Exhibit 24 (Power of Attorney) attached to the filing.

Context This transaction reflects issuance of dividend-equivalent stock units tied to earlier performance awards rather than a cash purchase or sale. Such awards typically follow the vesting and payout schedule of the underlying performance units and do not necessarily indicate immediate buying or selling by the insider. The filing appears to be a standard Form 4 reporting the grant/credit of units; no 10b5-1 plan, tax withholding sale, or late-filing flag is indicated in the provided excerpt.